CDC-RFA-EH-23-0004: Radiation protection of workers and the public by state and local radiation control programs
Closed
This grant is closed. A newer notice from the same program is open now: NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) (PA-27-100). Status: Due dates in the notice, expires April 5, 2027. It is in our archive of Centers for Disease Control - NCEH notices from 2023.
Centers for Disease Control - NCEH offered grants of up to $110,000 (at least $110,000) to any type of organization. It expected to make one award worth $550,000 in total. Applications closed on June 13, 2023.
From the official notice on Grants.gov, last changed April 13, 2023. Checked November 7, 2026.
- Award ceiling$110,000
- Award floor$110,000
- Total funding$550,000
- Expected awards1
- Cost sharingNot required
- Funding typeGrant
Key dates
| Posted | April 7, 2023 |
|---|---|
| Deadline | June 13, 2023 |
| Archived by Grants.gov | July 13, 2023 |
Who can apply
This opportunity was open to any type of organization.
All 13 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Private institutions of "higher education" are eligible so long as they are not for profit.
Is this a realistic fit?
- Past Environmental Public Health and Emergency Response awards averaged $1.2 million; this notice allows up to $110,000 per award.
- Most of the program's money (73% over five years) went to state and local governments.
- No cost sharing or match is required.
What the grant funds
The purpose of this NOFO is to continue to support state and local radiation control programs by leveraging their collective knowledge and expertise to support addressing radiological health issues of mutual interest. This project will be executed using a multi-faceted approach that includes joint working groups assigned to address specific issues, participating in committee and annual meetings to present and discuss issues of mutual interest, share information on new developments in the various areas of radiation protection as well as sharing challenges and seeking recommendations through collaboration with other state and local radiation subject matter expertise. The NOFO will support the development of guidance, recommendations, suggested state regulations and exchange of information in an effort to increase the existing tools, knowledge, and capabilities for radiological health staff throughout the country. Because many State radiation control programs have very limited resources to tackle the public health issues that impact their communities, it is anticipated this funding will leverage and help increase their collective capabilities to assure radiation protection of the public and workers. Funding this project will result in an overall reduction of risk, illness, and death associated with unnecessary exposure to radiation.
Who has won Environmental Public Health and Emergency Response grants before
From fiscal 2021 to 2025, Environmental Public Health and Emergency Response (93.070) awarded $213 million across 183 grant awards, an average of $1.2 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Michigan Department of Health and Human Services | Michigan | 6 | $11.9 million |
| Minnesota Department of Health | Minnesota | 6 | $7.8 million |
| Florida Department of Health | Florida | 4 | $6.5 million |
| New Hampshire Department of Health & Human Services | New Hampshire | 4 | $6.2 million |
| State of Wisconsin Department of Health Services | Wisconsin | 5 | $6.0 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, PA-27-100, which is open now.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is CDC-RFA-EH-23-0004 still open?
No. It closed on June 13, 2023. A newer notice is open: PA-27-100, due dates in the notice, expires April 5, 2027.
Who can apply for Radiation protection of workers and the public by state and local radiation control programs?
Centers for Disease Control - NCEH accepted applications from any type of organization. The notice adds further conditions, so read its eligibility section.
What is the deadline for Radiation protection of workers and the public by state and local radiation control programs?
Closed June 13, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $110,000 each. About $550,000 in total for one award.
Who has won Environmental Public Health and Emergency Response grants before?
The largest recipients over five fiscal years were Michigan Department of Health and Human Services, Minnesota Department of Health, Florida Department of Health. The program made 183 awards worth $213 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)